Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Malignant Solid TumorHematologic Malignancies
Interventions
DEVICE

Biometric Devices

Patients will wear two devices: HealthPatch Sensor and Phillips Actiwatch. Health data (e.g. average steps per day, resting heart rate) will be collected and monitored over the course of a cycle of cytotoxic chemotherapy.

OTHER

Physical Performance Testing

Patients will complete a CPET and 6 minute walk test within one week of starting an upcoming chemotherapy cycle and they will undergo a second CPET upon completion of said chemotherapy cycle.

Trial Locations (1)

27514

Lineberger Comprehensive Cancer Center, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

UNC Lineberger Comprehensive Cancer Center

OTHER